Previous Close | 15.45 |
Open | 15.55 |
Bid | 16.15 |
Ask | 16.70 |
Strike | 45.00 |
Expire Date | 2024-06-21 |
Day's Range | 15.45 - 15.55 |
Contract Range | N/A |
Volume | |
Open Interest | 387 |
Novo Nordisk was the talk of the pharma and medical world this year — and also the world of People magazine and E! with stars from Amy Schumer to Elon Musk using the firm’s diabetes and weight-loss medicines, Ozempic and Wegovy. This is partly why Novo Nordisk is Yahoo Finance's 2023 Company of the Year.
In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, […]
NEW YORK, December 10, 2023--Pfizer Inc. (NYSE: PFE) today presented results from the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab for the treatment of people with severe hemophilia A and moderately severe to severe hemophilia B without inhibitors to Factor VIII (FVIII) or Factor IX (FIX). The results from the BASIS trial demonstrated a statistically significant and clinically meaningful effect on annualized bleeding rate (ABR). The findings were presented today at t